年度财报
Exagen(XGN)03-18 21:35
$Exagen(XGN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001274737-24-000022 Act: 34 Size: 9 MB 网页链接
简介：Exagen Inc.成立于2002年。Exagen致力于通过及时鉴别诊断和优化治疗干预，改变患有衰弱和慢性自身免疫疾病的患者的护理连续体。该公司的目标是通过鉴别诊断，预后和监测复杂的自身免疫和自身免疫相关疾病（包括SLE和类风湿性关节炎或RA），使风湿病学家能够改善对患者的护理。
| 今开：1.43 | 昨收：1.43 |
| 最高：1.445 | 最低：1.3003 |
| 涨停价： | 跌停价： |
| 总市值：24128328 |
Exagen(XGN)03-18 21:35
$Exagen(XGN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001274737-24-000022 Act: 34 Size: 9 MB 网页链接
Exagen(XGN)03-18 20:05
$Exagen(XGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001274737-24-000019 Act: 34 Size: 338 KB 网页链接
Exagen(XGN)03-05 05:15
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000015 Size: 4 KB 网页链接
Exagen(XGN)03-07 05:15
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000017 Size: 6 KB 网页链接
Exagen(XGN)02-23 05:15
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000013 Size: 5 KB 网页链接
Exagen(XGN)02-23 05:15
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000012 Size: 5 KB 网页链接
Exagen(XGN)02-10 06:15
$Exagen(XGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000814133-24-000052 Act: 34 Size: 4 KB 网页链接
Exagen(XGN)02-13 19:15
$Exagen(XGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-032792 Act: 34 Size: 128 KB 网页链接
Exagen(XGN)02-14 05:45
$Exagen(XGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-24-000145 Act: 34 Size: 60 KB 网页链接
Exagen(XGN)02-14 20:15
$Exagen(XGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001550 Act: 34 Size: 65 KB 网页链接
蹊之美股生物医药2021-08-12 03:35
作者：林出
微信公众号：蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
$Exagen(XGN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001274737-24-000022 Act: 34 Size: 9 MB 网页链接
$Exagen(XGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001274737-24-000019 Act: 34 Size: 338 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000017 Size: 6 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000015 Size: 4 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000012 Size: 5 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-24-000013 Size: 5 KB 网页链接
$Exagen(XGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-24-000187 Act: 34 Size: 30 KB 网页链接
$Exagen(XGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001550 Act: 34 Size: 65 KB 网页链接
$Exagen(XGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-24-000145 Act: 34 Size: 60 KB 网页链接
$Exagen(XGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-032792 Act: 34 Size: 128 KB 网页链接